Riskpilot← Back to searchSign inGet full accessOLYMPUS NORGE AS
ASActiveOrg 950637323Drengsrudbekken 12, 1383 AskerWholesale of pharmaceutical and medical goods · NACE 4646Est. 198845 employees
Revenue 2025
NOK 409,3M
+9% vs 2024
EBITDA margin
8.6%
+22% vs 2024
Equity ratio
33.2%
Financial strength
Net profit 2025
NOK 24,2M
+6% vs 2024
| Revenue | NOK 409,3M | +9% |
| EBITDA | NOK 35,2M | +22% |
| Net profit | NOK 24,2M | +6% |
| Total assets | NOK 285,8M | +13% |
| Equity | NOK 94,8M | +34% |
| Employees | 45 | — |
Legal name
OLYMPUS NORGE AS
Org number
950637323
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
29. desember 1988
Share capital
—
Employees
45 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap eller ett styremedlem og daglig leder i fellesskap.
Address
Drengsrudbekken 12, 1383 Asker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 254 251 | 273 650 | 311 499 | 342 679 | 360 501 | 351 163 | 355 028 | 365 188 | 342 747 | 345 563 | 376 072 | 409 289 |
| Staff expenses | −34 216 | −43 131 | −49 196 | −54 482 | −55 286 | −54 753 | −57 497 | −0 | −53 224 | −0 | −0 | −0 |
| EBITDA | 26 328 | 16 325 | 19 618 | 22 297 | 24 818 | 28 413 | 29 922 | 23 669 | 26 268 | 32 035 | 28 834 | 35 180 |
| Depreciation & amort. | −972 | −821 | −1 156 | −1 318 | −2 922 | −2 746 | −2 598 | −2 736 | −3 386 | −9 044 | −9 423 | −8 840 |
| EBIT | 25 355 | 15 504 | 18 462 | 20 979 | 21 896 | 25 667 | 27 324 | 20 932 | 22 881 | 22 991 | 19 411 | 26 341 |
| Net financials | 2 523 | 995 | 43 | −399 | 410 | 1 004 | 1 341 | 2 385 | −711 | 2 263 | 9 881 | 4 714 |
| Profit before tax | 27 878 | 16 499 | 18 505 | 20 580 | 22 305 | 26 672 | 28 665 | 23 317 | 22 170 | 25 254 | 29 292 | 31 055 |
| Tax | 7 919 | 4 577 | −5 775 | 5 210 | 5 729 | 6 460 | 6 507 | 5 231 | 5 814 | −0 | −0 | −0 |
| Net profit | 19 959 | 11 922 | 24 280 | 15 370 | 16 576 | 20 211 | 22 159 | 18 086 | 16 356 | 19 632 | 22 801 | 24 181 |
| Item | 2008 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 97 104 | 93 597 | 136 020 | 177 918 | 201 239 | 210 197 | 207 863 | 198 823 | 216 005 | 234 142 | 252 813 | 285 786 |
| Equity | 37 799 | 35 543 | 40 819 | 53 324 | 60 372 | 63 059 | 68 901 | 73 962 | 68 901 | 82 298 | 70 599 | 94 780 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 346 | 23 478 | 23 533 |
| Short-term debt | 59 305 | 58 055 | 95 201 | 124 594 | 140 867 | 147 138 | 138 963 | 124 861 | 147 104 | 146 497 | 158 736 | 167 474 |
| Total debt | 59 305 | 58 055 | 95 201 | 124 594 | 140 867 | 147 138 | 138 963 | 124 861 | 147 104 | 151 843 | 182 214 | 191 006 |
EBITDA margin
8.6%
This company
15.8%
Market median
-46% vs market
20082025
Equity ratio
33.2%
This company
38.2%
Market median
+13% vs market
20082025
Return on equity
25.5%
This company
18.4%
Market median
+39% vs market
20082025
Net profit margin
5.9%
This company
8.1%
Market median
-27% vs market
20082025
Asset turnover
1.43×
This company
1.12×
Market median
+28% vs market
20082025
Debt / equity
2.02×
This company
0.62×
Market median
-226% vs market
20082025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2019-04-01 – 2020-03-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2018-04-01 – 2019-03-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2017-04-01 – 2018-03-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2016-04-01 – 2017-03-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2015-04-01 – 2016-03-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2014-04-01 – 2015-03-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2007-04-01 – 2008-03-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LG Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
YO Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Olympus Europa Se & Co.Kg. | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OLYMPUS NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Georg Rust | Chief Executive Officer | 0 companies |
| Yonna Olsson | Chief Executive Officer | 0 companies |
| Christiane Iwanoff | Chairman | 0 companies |
| Denniz Städtke-Morgenroth | Board of Directors | 0 companies |
| Joanna Szwiec | Board of Directors | 0 companies |
| Carl Constantin Zangemeister | Chairman | 0 companies |
| Rolf Inge Karlsen | Chairman | 0 companies |